This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Maliakkal, R. J. Articles by Elashoff, R. Search for Related Content PubMed PubMed Citation Articles by Maliakkal, R. J. Articles by Elashoff, R. Social Bookmarking                         What's this?

Optimal Design of Clinical Outcome Studies in Nutrition and Cancer: Future Directions

New England Deaconess Hospital, Harvard Medical School, Boston, Massachusetts, Clinical Homecare, Ltd, Fairfield, New Jersey, Cancer Treatment Centers of America, Evanston, Illinois, American International Hospital, Zion, Illinois, Cancer Center Base Unit, University of California, Los Angeles

George L. Blackburn, MD, PHD

New England Deaconess Hospital, Harvard Medical School, Boston, Massachusetts, Clinical Homecare, Ltd, Fairfield, New Jersey, Cancer Treatment Centers of America, Evanston, Illinois, American International Hospital, Zion, Illinois, Cancer Center Base Unit, University of California, Los Angeles

Harrison D. Willcutts, MD

New England Deaconess Hospital, Harvard Medical School, Boston, Massachusetts, Clinical Homecare, Ltd, Fairfield, New Jersey, Cancer Treatment Centers of America, Evanston, Illinois, American International Hospital, Zion, Illinois, Cancer Center Base Unit, University of California, Los Angeles

Michael Williams, MD, PHD

New England Deaconess Hospital, Harvard Medical School, Boston, Massachusetts, Clinical Homecare, Ltd, Fairfield, New Jersey, Cancer Treatment Centers of America, Evanston, Illinois, American International Hospital, Zion, Illinois, Cancer Center Base Unit, University of California, Los Angeles

Robert Levin, MD

New England Deaconess Hospital, Harvard Medical School, Boston, Massachusetts, Clinical Homecare, Ltd, Fairfield, New Jersey, Cancer Treatment Centers of America, Evanston, Illinois, American International Hospital, Zion, Illinois, Cancer Center Base Unit, University of California, Los Angeles

H. David Willcutts, JR

New England Deaconess Hospital, Harvard Medical School, Boston, Massachusetts, Clinical Homecare, Ltd, Fairfield, New Jersey, Cancer Treatment Centers of America, Evanston, Illinois, American International Hospital, Zion, Illinois, Cancer Center Base Unit, University of California, Los Angeles

Robert Elashoff, PHD

New England Deaconess Hospital, Harvard Medical School, Boston, Massachusetts, Clinical Homecare, Ltd, Fairfield, New Jersey, Cancer Treatment Centers of America, Evanston, Illinois, American International Hospital, Zion, Illinois, Cancer Center Base Unit, University of California, Los Angeles

Many studies have assessed the benefits of nutrition support in cancer patients. Except for studies directed at the treatment of severe malnutrition, most clinical trials have failed. Although prospective randomized controlled clinical trials (Phase III) remain the most reliable means of evaluating the efficacy of therapy, the available literature reports only results from small trials (Phase II to III), most of which appear to be contradictory and none of which conclusively answer the question being considered. To address this gap in knowledge, tools such as meta-analysis have been adapted from the field of statistics. Meta-analysis involves pooling results across several studies and provides a more precise estimate of treatment effect than can each individual study. However, clinical trials selected for meta-analysis, although broadly similar, can differ significantly in terms of therapies used and clinical populations studied. Major cancer types with differing effects on food intake and malnutrition (eg, the mechanical obstruction in head and neck cancer vs the cytokine-induced metastases associated with lung, ovarian, colon, and breast cancer) cannot be subject to the same analytic criteria. In this paper, the current state of clinical outcome trials in nutrition and cancer is examined, and the desired design for future studies is proposed. Research priorities include the conduct of Phase II clinical trials that use as outcome measures quality of life, performance status, and survival to identify optimal cancer-specific and patient-specific nutrition support. The next round of Phase III efficacy studies should establish the appropriate use of nutrition support in cancer therapy. (Journal of Parenteral and Enteral Nutrition 16: 112S-116S, 1992)

Journal of Parenteral and Enteral Nutrition, Vol. 16, No. 6 Suppl, 112S-116S (1992)
DOI: 10.1177/014860719201600614


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				D. A. August and D. Serrano Outcomes Research in Specialized Nutrition Support Nutr Clin Pract, December 1, 2007; 22(6): 602 - 608. [Abstract] [Full Text] [PDF]

				B. M. Wolfe and K. A. Mathiesen Clinical Practice Guidelines in Nutrition Support: Can They Be Based on Randomized Clinical Trials? JPEN J Parenter Enteral Nutr, January 1, 1997; 21(1): 1 - 6. [PDF]